Supplementary protection certificates (SPCs) allow for up to five and half years of additional patent protection for a medicinal product that has been authorised to […]

The end of the BREXIT transition period has no effect on European patents or patent applications. The European Patent Office (EPO) is European in name […]

A number of IP rights that apply across the European Union no longer apply to the United Kingdom, now that it has left the EU […]

A number of IP rights that apply across the European Union no longer apply to the United Kingdom, now that it has left the EU […]